Current issues in Tourette syndrome

Movement Disorders

Volumn 15, Issue 6, 2000, Pages 1051-1063

  Singer, Harvey S ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ANTIANDROGEN; BETA 2 ADRENERGIC RECEPTOR; CATECHOL METHYLTRANSFERASE; CLOMIPRAMINE; CLOZAPINE; DNA; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DRONABINOL; FLUTAMIDE; GLUCOCORTICOID RECEPTOR; GLUTAMATE RECEPTOR; GLYCINE; HALOPERIDOL; LAMOTRIGINE; NEUROLEPTIC AGENT; NORADRENALIN; OLANZAPINE; PERGOLIDE; PIMOZIDE; RECEPTOR SUBUNIT; RISPERIDONE; SEROTONIN 2 ANTAGONIST; SULPIRIDE; TIAPRIDE; UNINDEXED DRUG; ZIPRASIDONE;

AGE; ATTENTION DEFICIT DISORDER; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DYSESTHESIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC LINKAGE; GILLES DE LA TOURETTE SYNDROME; HEREDITY; HUMAN; LIMB MOVEMENT; LYME DISEASE; MALE; NEUROTRANSMITTER RELEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSION; PARESTHESIA; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; REVIEW; SENSORIMOTOR CORTEX; SEPARATION ANXIETY; SEROTONINERGIC SYSTEM; SIDE EFFECT; SLEEP; SYMPTOMATOLOGY;

ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOIMMUNITY; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROTRANSMITTER AGENTS; OBSESSIVE-COMPULSIVE DISORDER; PREVALENCE; SEVERITY OF ILLNESS INDEX; TIC DISORDERS; TOURETTE SYNDROME;

EID: 0033677539     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L     Document Type: Review

References (154)

1. Etude sur une affection nerveuse caracterisee par de l'incoordination motrice accompagnee d'echolalie et de copralalie
2. Vomiting and retching in Gilles de la Tourette syndrome: A report of ten cases and a review of the literature
3. Tourette syndrome: Another cause of movement disorder of the ear
4. 'Signing tics'-insights into the pathophysiology of symptoms in Tourette's syndrome
5. Sign language tics in a prelingually deaf man
6. Chronic persistent cough due to Gilles de la Tourette's syndrome
7. Quantitative study of spontaneous eye blinks and eye tics in Gilles de la Tourette's syndrome
8. Tourette's syndrome in patients referred for allergy evaluation
9. Tourette's syndrome mimicking asthma
10. Dermatological manifestations of Tourette syndrome and obsessive-compulsive disorder
11. Features resembling Tourette's syndrome in developmental stutterers
12. The temporal dynamics of tics in Gilles de la Tourette syndrome
13. Toward a better definition of the restless legs syndrome
14. Periodic limb movements during sleep are a frequent finding in Gilles de la Tourette's syndrome
15. Hyperkinetic movement disorders mis-diagnosed as tics in Gilles de la Tourette syndrome
16. Case study: Worsening Tourette's disorder or withdrawal dystonia?
17. Lyme disease presenting as Tourette's syndrome
18. Lamotrigine-induced tourettism
19. Clomipramine-induced tourettism in obsessive-compulsive disorder: Clinical and theoretical implications
20. Patient perception of tics and other movement disorders
21. Course of tic severity in Tourette syndrome: The first two decades
22. Adult tics in Gilles de la Tourette syndrome
23. Stimulant medication with-drawn during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
24. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
25. Advantages of a modified scoring method for the rush video-based tic rating scale
26. The Tourette syndrome diagnostic confidence index: Development and clinical associations
27. The prevalence of Tourette syndrome in a mainstream school population
28. Bilineal transmission in Tourette syndrome
29. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: A large scale study
30. Gilles de la Tourette's syndrome in special education schools: A United Kingdom study
31. Tourette syndrome in Oriental children: Clinical and pathophysiological consideration
32. Clinical characteristics of Tourette syndrome
33. A twin study of Tourette syndrome
34. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome
35. The inheritance of Gilles de la Tourette syndrome and associated behaviors: Evidence for autosomal dominant transmission
36. Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance
37. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome
38. Genome scan for linkage to Gilles de la Tourette syndrome
39. Peek-a-boo fragile site at 16d associated with Tourette syndrome, bipolar disorder, autistic disorder, and mental retardation
40. Linkage studies on Gilles de la Tourette syndrome: What is the strategy of choice?
41. The increasingly complex genetics of Tourette's syndrome
42. Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population
43. Nonreplication of linkage disequilibrium between the dopamine D4 receptor locus and Tourette syndrome
44. Linkage analysis of the dopamine D5 receptor gene and Gilles de la Tourette syndrome
45. Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients
46. The Bal I and Msp I polymorphisms in the dopamine D3 receptor gene display, linkage disequilibrium with each other but no association with Tourette syndrome
47. Neuroreceptor subunit genes and the genetic susceptibility to Gilles de la Tourette syndrome
48. Tourette syndrome and the norepinephrine transporter gene: Results of a systematic mutation screening
49. Catechol-O-methyltransferase and Gilles de la Tourette syndrome
50. Clinical features of Meige's disease (idiopathic orofacial dystonia): A report of 17 cases
51. Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature
52. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome
53. Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development
54. Clinical evidence of genomic imprinting in Tourette's syndrome
55. Investigation of the potential role of genetic imprinting in Gilles de la Tourette syndrome
56. Sex of parent transmission effect in Tourette's syndrome: Evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect
57. Hypothesis: Homozygosity in Tourette syndrome
58. Bilineal transmission in Tourette's syndrome families
59. Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree
60. Influence of family history on clinical expression of Tourette's syndrome
61. Prenatal and perinatal risk factors for Tourette disorder
62. The role of infection in the etiology of tics
63. Tourette's syndrome treated with ACTH and prednisone: Report of two cases
64. Tic disorders associated with evidence of invasive group A beta hemolytic streptococcal disease
65. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections PANDAS. A clinical description of the first fifty cases
66. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection
67. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections
68. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorder in childhood
69. Antibodies against human putamen in children with Tourette syndrome
70. Immune mechanisms in pediatric neuropsychiatric disorders. Tourette's syndrome, OCD, and PANDAS
71. Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome
72. Tic-like phonation and dyskinesia in rats after intracaudate microinfusion of sera from children with Tourette syndrome
73. Tourette's syndrome and 'PANDAS'; will the relation bear out?
74. Infection as an environmental stimuli in children with tic disorders
75. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever
76. Anti-neuronal antibodies in movement disorders
77. An immunoassay for antineuronal antibodies associated with involuntary repetitive movement disorders
78. Neurobiology of Tourette syndrome
79. Bilateral globus pallidus lesions in a patient with Tourette syndrome and related disorders
80. Tourette syndrome associated with unilateral cystic changes in the gyrus rectus
81. Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation
82. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome
83. A volumetric MRI study of Gilles de la Tourette's syndrome
84. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images
85. Subcortical volumes in female children with Tourette syndrome: Support for a gender effect
86. Corpus callosum morphology from magnetic resonance images in Tourette's syndrome
87. Morphology of the corpus callosum in children with Tourette syndrome and attention deficit hyperactivity disorder
88. Corpus callosum measurements in girls with Tourette syndrome
89. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome
90. Abnormal cerebral activation associated with a motor task in Tourette syndrome
91. Coexistence of tics and parkinsonism: Evidence for non-dopaminergic mechanisms in tic pathogenesis
92. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette syndrome
93. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding
94. Dopamine D2 receptor imaging in Gilles de la Tourette syndrome
95. D2-like dopamine receptor density in Tourette syndrome measured by PET
96. 123I] Beta-CIT SPECT imaging demonstrates increased striatal dopamine binding in Tourette's syndrome
97. Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity
98. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome
99. High presynaptic dopaminergic activity in children with Tourette's disorder
100. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome
101. Increased intrasynaptic dopamine release in Tourette's syndrome
102. The treatment of Tourette's syndrome: Multimodal, developmental intervention
103. Aggressive behavior in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder
104. Relaxation therapy in Tourette syndrome: A pilot study
105. 156 cases of Gilles de la Tourette's syndrome treated by acupuncture
106. Response of major depression and Tourette's syndrome to ECT: A case report
107. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus
108. Relative efficacy of haloperidol and pimozide in children with adolescents with Tourette disorder
109. Short-term versus longer term pimozide therapy in Tourette's syndrome: A preliminary study
110. Technetium-99m-HMPAO in Tourette's syndrome on neuroleptic therapy and after withdrawal
111. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
112. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: An open pilot dose-titration study with risperidone
113. Risperidone as a treatment for Tourette's syndrome
114. Risperidone in the treatment of Tourette syndrome: A retrospective case note study
115. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders
116. Olanzapine in Tourette's disorder
117. Olanzapine in Tourette's disorder
118. Effective open-label treatment of Tourette's disorder with olanzapine
119. Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study
120. Clozapine in Tourette's syndrome
121. The trial use of clozapine for abnormal involuntary movement disorders
122. Dopamine agonist treatment of Tourette disorder in children: Results of an open-label trial of pergolide
123. Tourette syndrome improvement with pergolide in a randomized, double-blind crossover trial
124. Talipexole and adult Gilles de la Tourette's syndrome: Double-blind, placebo-controlled clinical trial
125. Cannabinoids: Possible role in pathophysiology and therapy of Gilles de la Tourette syndrome
126. Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol
127. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome
128. Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research
129. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: An open study
130. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome
131. Nicotine for the treatment of Tourette's syndrome
132. Treatment of Tourette's syndrome with mecamylamine
133. Donepezil for Tourette's disorder and ADHD
134. Reserpine treatment of comorbid Tourette's disorder and tardive dystonia
135. Tics in Tourette syndrome: New treatment options
136. Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections
137. The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome
138. Ketanserin treatment of Tourette's syndrome in children
139. Ondansetron treatment in patients with Tourette's syndrome
140. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: A double-blind placebo-controlled study
141. Citalopram and fluvoxamine in Tourette's disorder
142. Gilles de la Tourette's syndrome: Familial occurrence and precipitation by methylphenidate therapy
143. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
144. The effect of central nervous system stimulants on Tourette syndrome
145. Stimulant medications precipitate Tourette's syndrome
146. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: Effects of methylphenidate treatment
147. Tics following methylphenidate administration: A report of 20 cases
148. Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability
149. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
150. Methylphenidate discontinuation and reinitiation during long-term treatment of children with Tourette's disorder and attention-deficit hyperactivity disorder: A pilot study
151. Guanfacine use in children with attention deficit hyperactivity disorder
152. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine
153. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder
154. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder